X0204 3/A 2012-02-06 2012-02-16 0 0000885590 Valeant Pharmaceuticals International, Inc. VRX 0001542052 Hall Susan VALEANT PHARMACEUTICALS INTERNATIONAL 7150 MISSISSAUGA ROAD MISSISSAUGA A6 L5N 8M5 ONTARIO, CANADA 0 1 0 0 Global Head of R&D Non-Qualified Stock Options (right to purchase) 13.24 2017-03-03 Common Shares, no par value 48360 D Non-Qualified Stock Options (right to purchase) 25.42 2015-11-11 Common Shares, no par value 23385 D Restricted Share Units 0 Common Shares, no par value 2313 D Restricted Share Units 0 Common Shares, no par value 4626 D The options vest 1/3 per year for 3 years starting from March 3, 2010 ("the vest from date") the date of grant with the first vest date falling on the first anniversary of "the vest from date," the second vest date falling on the second anniversary of "the vest from date" and the third vest date falling on the third anniversary of the "the vest from date." The options vest 25% per year for 4 years starting from October 8, 2010 ("the vest from date") with the first vest date falling on the first anniversary of "the vest from date," the second vest date falling on the second anniversary of "the vest from date," the third vest date falling on the third anniversary of "the vest from date" and the fourth vest date falling on the fourth anniversary of "the vest from date." Previously reported 31,179 in error. Each Restricted Share Unit ("RSUs") represents a contingent right to receive an equal number of common share, no par value, of Valeant Pharmaceuticals International, Inc. ("Valeant"), subject to performance based vesting criteria. See note (5). The performance based RSUs are eligible to vest on the achievement of TSR targets ranging from 15% to 45% over a base price on three separate measurement dates Each Restricted Share Unit ("RSUs") represents a contingent right to receive between zero and three common shares, no par value, of Valeant Pharmaceuticals International, Inc. ("Valeant"), subject to performance based vesting criteria. See note (7). The performance based RSUs are eligible to vest on the achievement of TSR targets ranging from 15% to 45% over a base price of $26.51 on each of three measurement dates: 25% would vest on June 28, 2013, 50% on September 28, 2013 and 25% on December 28, 2013, with early vesting possible at higher TSR levels. by: Nicholas Zanoni for Susan Hall 2012-03-08